selected scholarly activity
-
chapters
- Late-Life Anxiety Disorders. 253-264. 2018
- Substance Use Disorders in Late Life. 319-342. 2018
-
conferences
- Systematic Review and Meta-Analysis of the Association between FTO rs9939609 Obesity Polymorphism and Suicide in a Large-Scale Multiethnic Population. Genetic Epidemiology. 672-673. 2017
- Chronic pain in patients with opioid use disorder receiving methadone. Journal of the Neurological Sciences. 165-165. 2017
- The Role of Testosterone in Men and Women Undergoing Methadone Maintenance Treatment (MMT) for Opioid Addiction. Biological Psychiatry. 396S-396S. 2014
- Examination of the Mechanisms of Weight Gain in Patients with Depression. Biological Psychiatry. 184S-184S. 2011
-
journal articles
- Do we need urine drug screens in opioid addiction treatment: An observational study on self-report versus urine drug screens.. Addictive Behaviors Reports. 21:100575. 2025
- Recruitment rates, retention rates, and follow-up completion in a Brief Intervention and Contact trial for suicidal behavior: a feasibility study.. Pilot and Feasibility Studies. 11:50. 2025
- Effects of vaping on physical and mental health in at-risk populations (VAPE): mixed-methods study of motivations for and perspectives on vaping in patients with opioid use disorder.. BJPsych Open. 11:e75. 2025
- Canadian Network for Mood and Anxiety Treatments 2024 Clinical Practice Guideline for the Management of Perinatal Mood, Anxiety, and Related Disorders: Guide de pratique 2024 du Canadian Network for Mood and Anxiety Treatments pour le traitement des troubles de l'humeur, des troubles anxieux et des troubles connexes périnatals.. Canadian Journal of Psychiatry. 7067437241303031. 2025
- Hospital and physician-based mental healthcare during 12 months of opioid agonist treatment for opioid use disorder: Exploring costs and factors associated with acute care.. PLoS ONE. 20:e0314296. 2025
- Health service utilization, substance use treatment response, and death in patients with opioid use disorder and comorbid hepatitis C findings from prospective cohort study with administrative database linkage.. Journal of Substance Use and Addiction Treatment. 167:209524. 2024
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes. Canadian Journal of Psychiatry. 69:641-687. 2024
- Less focus on symptom scales in psychiatric trials: it is time to ensure research equality between psychiatry and other medical specialities. The Lancet Regional Health - Europe. 43:100993-100993. 2024
- Components of Outpatient Child and Youth Concurrent Disorders Programs: A Critical Interpretive Synthesis: Composantes des programmes de troubles concomitants des enfants et des jeunes ambulatoires : une synthèse interprétative critique. Canadian Journal of Psychiatry. 69:381-394. 2024
- Patient perspectives on pharmacogenomic (PGx) testing for antidepressant prescribing in primary care: a qualitative description study. Journal of Community Genetics. 15:293-309. 2024
- Assessing fragility of statistically significant findings from randomized controlled trials assessing pharmacological therapies for opioid use disorders: a systematic review. Trials. 25:286. 2024
- Primary outcome reporting in clinical trials for older adults with depression. BJPsych Open. 10:e60. 2024
- A genome-wide association, polygenic risk score and sex study on opioid use disorder treatment outcomes. Scientific Reports. 13:22360. 2023
- Association Between Mental Health Burden, Clinical Presentation, and Outcomes in Individuals With Symptomatic Peripheral Artery Disease: A Scientific Statement From the American Heart Association. Circulation. 148:1511-1528. 2023
-
Association between the
COVID ‐19 pandemic and psychiatric symptoms in people with preexisting obsessive‐compulsive, eating, anxiety, and mood disorders: a systematic review and meta‐analysis of before‐after studies. Psychiatry and Clinical Neurosciences. 77:583-591. 2023 - Heterogeneity across outcomes reported in clinical trials for older adults with depression: a systematic survey. Journal of Clinical Epidemiology. 157:59-73. 2023
- Integrating Psychosocial Care in the Management of Patients With Vascular Disease. Journal of the American College of Cardiology. 81:1201-1204. 2023
- Genetics of cannabis use in opioid use disorder: A genome-wide association and polygenic risk score study. PLoS ONE. 18:e0289059-e0289059. 2023
- Factors Associated With Increased Opioid Use During the COVID-19 Pandemic: A Prospective Study of Patients Enrolled in Opioid Agonist Treatment. Journal of Addiction Medicine. 16:e257-e264. 2022
- Sex-Specific Risk Factors and Health Disparity Among Hepatitis C Positive Patients Receiving Pharmacotherapy for Opioid Use Disorder: Findings From a Propensity Matched Analysis. Journal of Addiction Medicine. 16:e248-e256. 2022
- Cannabinoids in psychiatry: they are here to stay. The British journal of psychiatry. Supplement. 220:311-313. 2022
- Mirtazapine for the treatment of amphetamine and methamphetamine use disorder: A systematic review and meta-analysis. Drug and Alcohol Dependence. 232:109295-109295. 2022
- National suicide management guidelines recommending family-based prevention, intervention and postvention and their association with suicide mortality rates: systematic review. BJPsych Open. 8:e54. 2022
- Virtual psychiatric care fast-tracked: reflections inspired by the COVID-19 pandemic. BJPsych Bulletin. 46:33-36. 2022
- Cannabis use and opioid relapse: An exploratory survival analysis of prospectively collected data. Frontiers in Psychiatry. 13:1046649. 2022
- The Inclusion of Patients’ Reported Outcomes to Inform Treatment Effectiveness Measures in Opioid Use Disorder. A Systematic Review. Patient Related Outcome Measures. Volume 13:113-130. 2022
- A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder. Addiction Science & Clinical Practice. 16:70. 2021
- Cannabis use in patients treated for opioid use disorder pre- and post-recreational cannabis legalization in Canada. Substance Abuse: Treatment, Prevention, and Policy. 16:34. 2021
- Delirium and other neuropsychiatric manifestations of COVID-19 infection in people with preexisting psychiatric disorders: a systematic review. Journal of Medical Case Reports. 15:586. 2021
- Factors affecting participant recruitment and retention in borderline personality disorder research: a feasibility study. Pilot and Feasibility Studies. 7:178. 2021
- Factors associated with opioid overdose during medication-assisted treatment: How can we identify individuals at risk?. Harm Reduction Journal. 18:71. 2021
- Identifying patient-important outcomes for treatment of bipolar disorder: a systematic review protocol. BMJ Open. 11:e050453-e050453. 2021
- Problematic Opioid Use Among Older Adults: Epidemiology, Adverse Outcomes and Treatment Considerations. Drugs and Aging. 38:1043-1053. 2021
- Sensitivity and specificity of self-reported psychiatric diagnoses amongst patients treated for opioid use disorder. BMC Psychiatry. 21:520. 2021
- The association between cannabis use and outcome in pharmacological treatment for opioid use disorder. Harm Reduction Journal. 18:24. 2021
- Corrigendum to ‘A comparison of electronically-delivered and face to face cognitive behavioural therapies in depressive disorders: A systematic review and meta-analysis’ [EClinicalMedicine 24 (2020) 100442]. EClinicalMedicine. 41:101182-101182. 2021
- Outcomes reported in randomised controlled trials of major depressive disorder in older adults: protocol for a methodological review. BMJ Open. 11:e054777-e054777. 2021
- Investigating and addressing the immediate and long-term consequences of the COVID-19 pandemic on patients with substance use disorders: a scoping review and evidence map protocol. BMJ Open. 11:e045946-e045946. 2021
- The Role of Cannabis Use in Suicidal Ideation Among Patients With Opioid Use Disorder. Journal of Addiction Medicine. 15:370-375. 2021
- Genetic basis of cannabis use: a systematic review. BMC Medical Genetics. 14:203. 2021
- Patient-Reported Goals of Youths in Canada Receiving Medication-Assisted Treatment for Opioid Use Disorder. JAMA network open. 4:e2119600-e2119600. 2021
- Trauma and post-traumatic stress disorder in patients treated for opioid use disorder: findings from a 12-month cohort study. BJPsych Open. 7:e138. 2021
- Are patients’ goals in treatment associated with expected treatment outcomes? Findings from a mixed-methods study on outpatient pharmacological treatment for opioid use disorder. BMJ Open. 11:e044017-e044017. 2021
- Association between vaping and health outcomes in patients with opioid use disorder: a systematic review protocol. BMJ Open. 11:e040349-e040349. 2021
- Exploring the Impact of Modifiable Factors on Serum BDNF in Psychiatric Patients and Community Controls. Neuropsychiatric Disease and Treatment. Volume 17:545-554. 2021
- Global prevalence of burnout among postgraduate medical trainees: a systematic review and meta-regression. CMAJ open. 9:E189-E200. 2021
- Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in Ontario: Exploring sex differences. PLoS ONE. 16:e0261201-e0261201. 2021
- Leading from Behind: An Educational Intervention to Address Faculty and Learner Preparedness for Competence By Design in Psychiatry. Journal of Multidisciplinary Healthcare. Volume 14:2587-2595. 2021
- The Role of Perceived Social Support in the Association Between Stressful Life Events and Suicidal Behavior. Frontiers in Psychiatry. 12:699682. 2021
- The future of precision medicine in opioid use disorder: inclusion of patient-important outcomes in clinical trials. Revista Brasileira de Psiquiatria. 43:138-146. 2021
- A call for consensus in defining efficacy in clinical trials for opioid addiction: combined results from a systematic review and qualitative study in patients receiving pharmacological assisted therapy for opioid use disorder. Trials. 21:30. 2020
- Exploring the Association between Cannabis Use and Testosterone Levels in Men Receiving Methadone Maintenance Treatment. Psychiatry International. 1:67-74. 2020
- Feasibility of behavioral activation group therapy in reducing depressive symptoms and improving quality of life in patients with depression: the BRAVE pilot trial. Pilot and Feasibility Studies. 6:61. 2020
- GWAS-identified genetic variants associated with medication-assisted treatment outcomes in patients with opioid use disorder: a systematic review and meta-analysis protocol. Systematic Reviews. 9:200. 2020
- Genetic determinants of cannabis use: a systematic review protocol. Systematic Reviews. 9:190. 2020
- Reporting of methodological studies in health research: a protocol for the development of the MethodologIcal STudy reportIng Checklist (MISTIC). BMJ Open. 10:e040478-e040478. 2020
- Social functioning outcomes in men and women receiving medication-assisted treatment for opioid use disorder. Biology of Sex Differences. 11:20. 2020
- Addendum to ‘A comparison of electronically-delivered and face to face cognitive behavioural therapies in depressive disorders: A systematic review and meta-analysis’ [EClinicalMedicine 24 (2020) 100442]. EClinicalMedicine. 27:100580-100580. 2020
- The association of HTR2A polymorphisms with obsessive-compulsive disorder and its subtypes: A meta-analysis. Journal of Affective Disorders. 275:278-289. 2020
- Impact of COVID-19 and other pandemics and epidemics on people with pre-existing mental disorders: a systematic review protocol and suggestions for clinical care. BMJ Open. 10:e040229-e040229. 2020
- Behavioural activation therapy for depression in adults. Cochrane Database of Systematic Reviews. 7:CD013305. 2020
- A comparison of electronically-delivered and face to face cognitive behavioural therapies in depressive disorders: A systematic review and meta-analysis. EClinicalMedicine. 24:100442-100442. 2020
- National suicide management guidelines with family as an interv’ention and suicide mortality rates: a systematic review protocol. BMJ Open. 10:e034694-e034694. 2020
- Evaluation of BDNF as a Biomarker for Impulsivity in a Psychiatric Population. Diagnostics. 10:419-419. 2020
- The impact of chronic liver disease in patients receiving active pharmacological therapy for opioid use disorder: One-year findings from a prospective cohort study. Drug and Alcohol Dependence. 209:107917-107917. 2020
- Canadian Guidelines on Opioid Use Disorder Among Older Adults. Canadian Geriatrics Journal. 23:123-134. 2020
- <p>Children and Youth Who Use Cannabis for Pain Relief: Benefits, Risks, and Perceptions</p>. Adolescent Health, Medicine and Therapeutics. Volume 11:53-61. 2020
- Exploring psychological symptoms and associated factors in patients receiving medication-assisted treatment for opioid-use disorder. BJPsych Open. 6:e8. 2020
- Psychosis and Comorbid Opioid Use Disorder: Characteristics and Outcomes in Opioid Substitution Therapy. Schizophrenia Bulletin Open. 1. 2020
- Treatment Outcomes in Patients With Opioid Use Disorder Who Were First Introduced to Opioids by Prescription: A Systematic Review and Meta-Analysis. Frontiers in Psychiatry. 11:812. 2020
- Sociodemographic characteristics of patients with children in a methadone maintenance program: a cross-sectional study. Harm Reduction Journal. 16:13. 2019
- The association between health conditions and cannabis use in patients with opioid use disorder receiving methadone maintenance treatment. BJPsych Open. 5:e91. 2019
- Cannabis use during methadone maintenance treatment for opioid use disorder: a systematic review and meta-analysis. CMAJ open. 7:E665-E673. 2019
- Feasibility and implementation of a healthy lifestyles program in a community setting in Ontario, Canada: protocol for a pragmatic mixed methods pilot study. BMJ Open. 9:e031298-e031298. 2019
- Adverse Outcomes Associated with Prescription Opioids for Acute Low Back Pain: A Systematic Review and Meta-Analysis. Pain Physician. 2:119-138. 2019
- Patient Experiences and Opinions of a Behavioral Activation Group Intervention for Depression. Research on Social Work Practice. 29:10-18. 2019
- A systematic review of comparisons between protocols or registrations and full reports in primary biomedical research. BMC Medical Research Methodology. 18:9. 2018
- Association Between Family Factors and Illicit Polysubstance Use Amongst Methadone Maintenance Patients with Opioid Use Disorder. International Journal of High Risk Behaviors and Addiction. 7. 2018
- Identifying patient-important outcomes in medication-assisted treatment for opioid use disorder patients: a systematic review protocol. BMJ Open. 8:e025059-e025059. 2018
- The association between cannabis use and suicidal behavior in patients with psychiatric disorders: an analysis of sex differences. Biology of Sex Differences. 9:22. 2018
- Treatment outcomes in patients with opioid use disorder initiated by prescription: a systematic review protocol. Systematic Reviews. 7:16. 2018
- Association Between Socio-Demographic and Health Functioning Variables Among Patients with Opioid Use Disorder Introduced by Prescription: A Prospective Cohort Study.. Pain Physician. 21:E623-E632. 2018
- A Systematic Survey of Control Groups in Behavioral and Social Science Trials. Research on Social Work Practice. 28:538-545. 2018
- Evaluating Completeness of Reporting in Behavioral Interventions Pilot Trials. Research on Social Work Practice. 28:577-584. 2018
- Enhancing primary reports of randomized controlled trials: Three most common challenges and suggested solutions. Proceedings of the National Academy of Sciences of the United States of America. 115:2595-2599. 2018
- Exploring metabolic factors and health behaviors in relation to suicide attempts: A case-control study. Journal of Affective Disorders. 229:386-395. 2018
- Does the medical literature remain inadequately described despite having reporting guidelines for 21 years? – A systematic review of reviews: an update. Journal of Multidisciplinary Healthcare. Volume 11:495-510. 2018
- Enhancing research publications and advancing scientific writing in health research collaborations: sharing lessons learnt from the trenches. Journal of Multidisciplinary Healthcare. Volume 11:245-254. 2018
- Exploring the characteristics, global distribution and reasons for retraction of published articles involving human research participants: a literature survey. Journal of Multidisciplinary Healthcare. Volume 11:39-47. 2018
- Profile of suicide attempts and risk factors among psychiatric patients: A case-control study. PLoS ONE. 13:e0192998-e0192998. 2018
- The effect of cannabis exposure on pubertal outcomes: a systematic review. Adolescent Health, Medicine and Therapeutics. Volume 9:137-147. 2018
- Volumetric MRI Analysis of a Case of Severe Ventriculomegaly. Frontiers in Human Neuroscience. 12:495. 2018
- A scoping review of comparisons between abstracts and full reports in primary biomedical research. BMC Medical Research Methodology. 17:181. 2017
- Adverse outcomes associated with opioid prescription for acute low back pain: a systematic review protocol. Systematic Reviews. 6:163. 2017
- Association between cannabis use and methadone maintenance treatment outcomes: an investigation into sex differences. Biology of Sex Differences. 8:8. 2017
- Sex differences in social risk factors for suicidal behaviour. Mental Health and Prevention. 8:1-6. 2017
- The association between age of onset of opioid use and comorbidity among opioid dependent patients receiving methadone maintenance therapy. Addiction Science & Clinical Practice. 12:9. 2017
- Acceptability of the Fitbit in behavioural activation therapy for depression: a qualitative study. Evidence-Based Mental Health. 20:128-133. 2017
- Influence of depression on genetic predisposition to type 2 diabetes in a multiethnic longitudinal study. Scientific Reports. 7:1629. 2017
- State of reporting of primary biomedical research: a scoping review protocol. BMJ Open. 7:e014749-e014749. 2017
- The Genetics of Opioid Addiction Risk Evaluation Tool (GREAT) for Treatment Response in Methadone Patients. International Journal of High Risk Behaviors and Addiction. 6. 2017
- Adult ADHD: Questioning Diagnosis and Treatment in a Patient with Multiple Psychiatric Comorbidities. Case Reports in Psychiatry. 2017:1-7. 2017
- The impact of comorbid psychiatric disorders on methadone maintenance treatment in opioid use disorder: a prospective cohort study. Neuropsychiatric Disease and Treatment. Volume 13:1399-1408. 2017
- “Don’t Judge a Book by Its Cover”: A Qualitative Study of Methadone Patients’ Experiences of Stigma. Substance Use: Research and Treatment. 11:117822181668508-117822181668508. 2017
- Association between cannabis use and treatment outcomes in patients receiving methadone maintenance treatment: a systematic review protocol. Systematic Reviews. 5:139. 2016
- Behavioral activation group therapy for reducing depressive symptoms and improving quality of life: a feasibility study. Pilot and Feasibility Studies. 2:22. 2016
- Body Mass Index Is an Important Predictor for Suicide: Results from a Systematic Review and Meta‐Analysis. Suicide and Life-Threatening Behavior. 46:697-736. 2016
- Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a systematic review and meta-analysis. Systematic Reviews. 5:189. 2016
- Exploring the Association between Serum BDNF and Attempted Suicide. Scientific Reports. 6:25229. 2016
- Pain and Opioid Addiction: A Systematic Review and Evaluation of Pain Measurement in Patients with Opioid Dependence on Methadone Maintenance Treatment. Current Drug Research Reviews. 9:49-60. 2016
- Light therapy for non-seasonal depression: systematic review and meta-analysis. BJPsych Open. 2:116-126. 2016
- Usefulness of the Brief Pain Inventory in Patients with Opioid Addiction Receiving Methadone Maintenance Treatment. Pain Physician. 1;19:E181-E195. 2016
- Somatic symptom disorder, a new DSM-5 diagnosis of an old clinical challenge. BMJ Case Reports. 2016:bcr2015212553-bcr2015212553. 2016
- A Prospective Study to Investigate Predictors of Relapse among Patients with Opioid Use Disorder Treated with Methadone. Substance Use: Research and Treatment. 10:SART.S37030-SART.S37030. 2016
- Best (but oft-forgotten) practices: sensitivity analyses in randomized controlled trials. American Journal of Clinical Nutrition. 103:5-17. 2016
- Neuropsychological Impact of West Nile Virus Infection: An Extensive Neuropsychiatric Assessment of 49 Cases in Canada. PLoS ONE. 11:e0158364-e0158364. 2016
- Obesity Genes and Risk of Major Depressive Disorder in a Multiethnic Population. Journal of Clinical Psychiatry. 76:e1611-e1618. 2015
- A pragmatic pilot randomized trial to investigate the effectiveness of behavioural activation group therapy in reducing depressive symptoms and improving quality of life in patients with depression: the BRAVE pilot trial protocol. Pilot and Feasibility Studies. 1:39. 2015
- Association between BDNF levels and suicidal behaviour: a systematic review and meta-analysis. Systematic Reviews. 4:187. 2015
- Association between BDNF levels and suicidal behaviour: a systematic review protocol. Systematic Reviews. 4:56. 2015
- Association between body mass index and suicidal behaviors: a systematic review protocol. Systematic Reviews. 4:52. 2015
- Contribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: an observational study. Addiction Science & Clinical Practice. 10:19. 2015
- Exploring the Determinants of Suicidal Behavior: Conventional and Emergent Risk (DISCOVER): a feasibility study. Pilot and Feasibility Studies. 1:17. 2015
- Opioid substitution and antagonist therapy trials exclude the common addiction patient: a systematic review and analysis of eligibility criteria. Trials. 16:475. 2015
- Sex differences in substance use, health, and social functioning among opioid users receiving methadone treatment: a multicenter cohort study. Biology of Sex Differences. 6:21. 2015
- The impact of chronic pain on opioid addiction treatment: a systematic review protocol. Systematic Reviews. 4:49. 2015
- Sex differences in outcomes of methadone maintenance treatment for opioid use disorder: a systematic reviewand meta-analysis. CMAJ open. 3:E344-E351. 2015
- Lack of association between type 2 diabetes and major depression: epidemiologic and genetic evidence in a multiethnic population. Translational Psychiatry. 5:e618-e618. 2015
- Re-Examination of Classic Risk Factors for Suicidal Behavior in the Psychiatric Population. Crisis. 36:231-240. 2015
- Testosterone suppression in opioid users: A systematic review and meta-analysis. Drug and Alcohol Dependence. 149:1-9. 2015
- Impact of Chronic Pain on Treatment Prognosis for Patients with Opioid Use Disorder: A Systematic Review and Meta-analysis. Substance Use: Research and Treatment. 9:SART.S30120-SART.S30120. 2015
- Sex differences in outcomes of methadone maintenance treatment for opioid addiction: a systematic review protocol. Systematic Reviews. 3:45. 2014
- The effectiveness of opioid substitution treatments for patients with opioid dependence: a systematic review and multiple treatment comparison protocol. Systematic Reviews. 3:105. 2014
- Methadone induces testosterone suppression in patients with opioid addiction. Scientific Reports. 4:6189. 2014
- Commentary on ‘Elm et al’. Clinical Trials. 11:473-475. 2014
- An Overview of Pharmacogenetics in Psychotropic Drugs. Current Psychiatry Research and Reviews. 10:182-191. 2014
- Editorial (Thematic Issue: Genetics: A Window into the Biology of the Mind). Current Psychiatry Research and Reviews. 10:89-90. 2014
- Genetics of Opioid Dependence: A Review of the Genetic Contribution to Opioid Dependence. Current Psychiatry Research and Reviews. 10:156-167. 2014
- What is the role of Vitamin D in depression?. Psychiatric Times. 31. 2014
- Efficacy of Vitamin D Supplementation in Depression in Adults: A Systematic Review. Journal of Clinical Endocrinology and Metabolism (JCEM). 99:757-767. 2014
- Evaluation of clinical and inflammatory profile in opioid addiction patients with comorbid pain: results from a multicenter investigation. Neuropsychiatric Disease and Treatment. 10:2239-2239. 2014
- Genetic influence on methadone treatment outcomes in patients undergoing methadone maintenance treatment for opioid addiction: a pilot study. Neuropsychiatric Disease and Treatment. 10:1503-1503. 2014
- Impact of ABCB1 and CYP2B6 Genetic Polymorphisms on Methadone Metabolism, Dose and Treatment Response in Patients with Opioid Addiction: A Systematic Review and Meta-Analysis. PLoS ONE. 9:e86114-e86114. 2014
- A tutorial on sensitivity analyses in clinical trials: the what, why, when and how. BMC Medical Research Methodology. 13:92. 2013
- Efficacy of vitamin D supplementation in depression in adults: a systematic review protocol. Systematic Reviews. 2:64. 2013
- Erratum: The protective effect of the obesity-associated rs9939609 A variant in fat mass- and obesity-associated gene on depression. Molecular Psychiatry. 18:1324-1324. 2013
- The protective effect of the obesity-associated rs9939609 A variant in fat mass- and obesity-associated gene on depression. Molecular Psychiatry. 18:1281-1286. 2013
- South Asian Heart Risk Assessment (SAHARA): Randomized Controlled Trial Design and Pilot Study. JMIR Research Protocols. 2:e33-e33. 2013
- Vitamin D deficiency and depression in adults: systematic review and meta-analysis. The British journal of psychiatry. Supplement. 202:100-107. 2013
- A systematic scoping review of adherence to reporting guidelines in health care literature. Journal of Multidisciplinary Healthcare. 6:169-169. 2013
- The role of the serotonergic system in suicidal behavior. Neuropsychiatric Disease and Treatment. 9:1699-1699. 2013
- Smoking Cessation Intervention in a Cardiovascular Hospital Based Clinical Setting. Cardiovascular Psychiatry and Neurology. 2012:1-7. 2012
- The association of attempted suicide with genetic variants in the SLC6A4 and TPH genes depends on the definition of suicidal behavior: a systematic review and meta-analysis. Translational Psychiatry. 2:e166-e166. 2012
- The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and select comorbid medical conditions.. Annals of Clinical Psychiatry. 24:91-109. 2012
- Does Depression Impact Cognitive Impairment in Patients with Heart Failure?. Cardiology Research and Practice. 2012:1-9. 2012
- Methylenetetrahydrofolate Reductase Gene Variant (MTHFR C677T) and Migraine: A Case Control Study and Meta-analysis. BMC Neurology. 11:66. 2011
- Diagnosing migraine in research and clinical settings: The validation of the Structured Migraine Interview (SMI). BMC Neurology. 10:7. 2010
- Effectiveness of an Online Pediatric Primary Care Curriculum. Academic Pediatrics. 10:131-137. 2010
- Depression, Migraine With Aura and Migraine Without Aura: Their Familiality and Interrelatedness. Cephalalgia. 29:848-854. 2009
- Migraine in recurrent depression: case–control study. The British journal of psychiatry. Supplement. 194:350-354. 2009
- Factitious disorder presenting as type 1 diabetes mellitus. BMJ Case Reports. 2009:bcr0720080463-bcr0720080463. 2009
- A postmenopausal woman presenting with Ekbom syndrome associated with recurrent depressive disorder: a case report. Cases Journal. 1:54. 2008
- Depression, migraine, and cardiovascular disease: Sadness really can break your heart. Journal of Psychosomatic Research. 65:103-106. 2008
- Subacute alteration in level of consciousness in a woman with psychotic depression.. Journal of Psychiatry & Neuroscience. 33:E1-E2. 2008
-
preprints
- Factors Associated with Opioid Overdose During Medication-Assisted Treatment: How Can We Identify Individuals at Risk? 2020
- A Call for Consensus in Defining Efficacy in Clinical Trials for Opioid Addiction: Combined Results from a Systematic Review and Qualitative Study in Patients Receiving Pharmacological Assisted Therapy for Opioid Use Disorder 2019
- A Call for Consensus in Defining Efficacy in Clinical Trials for Opioid Addiction: Combined Results from a Systematic Review and Qualitative Study in Patients Receiving Pharmacological Assisted Therapy for Opioid Use Disorder 2019
- Full A Call for Consensus in Defining Efficacy in Clinical Trials for Opioid Addiction: Combined Results from a Systematic Review and Qualitative Study in Patients Receiving Pharmacological Assisted Therapy for Opioid Use Disorder 2019